A5036000745- Polyomavirus and related diseases
- Autoimmune Bullous Skin Diseases
- Cutaneous Melanoma Detection and Management
- Pharmaceutical Economics and Policy
- Pharmaceutical industry and healthcare
- Cancer Immunotherapy and Biomarkers
- Cutaneous lymphoproliferative disorders research
- Pharmaceutical studies and practices
- Cancer and Skin Lesions
- Viral-associated cancers and disorders
- Herpesvirus Infections and Treatments
- Tumors and Oncological Cases
- Oral and gingival health research
- Digital Imaging in Medicine
- Urticaria and Related Conditions
- Hereditary Neurological Disorders
- Radio Frequency Integrated Circuit Design
- Organ and Tissue Transplantation Research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- CAR-T cell therapy research
Inserm
2024
Centre National de la Recherche Scientifique
2024
Immunologie et Nouveaux Concepts en Immunothérapie
2024
Centre d'Investigation Clinique de Nantes
2023
Centre Hospitalier Universitaire de Nantes
2020-2023
Pruritus is a common symptom of bullous pemphigoid (BP), but has been poorly studied. The aim this study was to analyse the characteristics pruritus in patients with BP and its impact on their quality life. A multicentre prospective observational (in 15 French hospitals) performed. total 60 were included, mean age 77.4 years. occurred daily 85% patients, intensity 5.2/10. Tingling sensations present 72.4% burning 68.9%. exacerbated by stress, fatigue xerosis. ItchyQol score 56.2/110 5-D Itch...
Drug shortages have increased in recent years, and every country worldwide has been affected. The French Ministry of Health asked various scientific societies to establish a list ‘critical’ drugs for each specialty. aim this is enable the public authorities control chain production guarantee availability drugs. We present critical dermatological drugs, which result strong consensus between all representative entities Society Dermatology.